Target intelligence / Profile preview

TAB2 antisense RNA 1 (TAB2-AS1)

Target
TAB2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

TAB2 antisense RNA 1 (TAB2-AS1) is a long non-coding RNA transcribed in the antisense direction relative to the TAB2 gene. It is primarily expressed in ovarian granulosa cells and plays a key role in cellular processes including mitigation of oxidative stress, inhibition of apoptosis, and regulation of cell proliferation. The expression of TAB2-AS1 is controlled epigenetically by DNA methylation, and it promotes the expression of the TAB2 gene via sequence-specific RNA binding. TAB2-AS1 functions as a regulatory RNA, rather than a protein-coding gene. Experimental modulation (overexpression or knockdown) of TAB2-AS1 directly affects cellular oxidative state and follicular growth, suggesting a potential application as a therapeutic target in reproductive biology and possibly other oxidative stress-associated diseases

Other names
TAB2-ASlncRNA TAB2 antisense RNAMSTRG143.1
02

Mechanism of action

For drugs or molecules targeting TAB2-AS1, the mechanism includes regulation of expression via DNA methylation changes, which alters transcriptional activity of TAB2-AS1 and its ability to promote TAB2 mRNA stability and expression

03

Biological functions

Regulation of oxidative stressInhibition of apoptosisPromotion of cell proliferation (specifically granulosa cells in ovaries)Epigenetic regulation (via DNA methylation affecting transcription)Regulation of TAB2 gene expression through RNA-RNA binding
04

Disease associations

Follicular development disorderspossibly relevant to reproductive health and ovarian diseaseOther disease roles not yet well established in the literature; further research warranted.
05

Safety considerations

Therapeutic targeting of lncRNAs may have challenges such as off-target effects, potential interference with normal gene regulation, and delivery to specific cell typesNo specific clinical safety data are available for TAB2-AS1
06

Interacting drugs

5-Aza-CdR
07

Biomarkers

Expression levels of TAB2-AS1 in granulosa cells as a biomarker of follicular growth and oxidative stress responseCpG methylation status in TAB2-AS1 promoter region may serve as an epigenetic biomarker

Beyond the preview

Go deeper on TAB2 antisense RNA 1 (TAB2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAB2 antisense RNA 1 (TAB2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call